Streetbeat News

Stock Prices

PFE

In the last quarter, Pfizer (NYSE:PFE) has received various analyst ratings, with the majority being somewhat bullish or indifferent. Over the past 3 months, 11 analysts have offered 12-month price targets for Pfizer, with an average price target of $53.09, an increase of 6.44% from the previous average price target of $49.88.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 8:01 pm

SONY

Sony Group (NYSE:SONY) has outperformed the market over the past 10 years, producing an average annual return of 14.93%. If an investor had bought $100 of SONY stock 10 years ago, it would be worth $407.86 today.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 8:00 pm

FIS

Over the past 3 months, 10 analysts have published their opinion on Fidelity National Info (NYSE:FIS) stock. The average price target is $74.0, a 3.36% decrease from the previous average price target of $76.57. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 8:00 pm

ABNB

Airbnb (NASDAQ:ABNB) has received 25 analyst ratings in the last quarter, with an average price target of $141.72, indicating an upside from the current price of $126.82. The average price target has increased by 12.06% from the previous average of $126.47.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 8:00 pm

PLRX

Analysts have provided bullish and somewhat bullish ratings for Pliant Therapeutics (NASDAQ:PLRX) in the last quarter. The average price target is $52.38, indicating a significant upside from the current price of $16.945. The average has increased by 1.37% from the previous target of $51.67.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 8:00 pm

NCNO

Ncino (NASDAQ:NCNO) has received a mix of analyst ratings in the last quarter, with 1 bullish, 3 somewhat bullish, and 7 indifferent. The average 12-month price target for Ncino is $28.27, which has increased by 13.99% over the past month.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 8:00 pm

SKWD

Skyward Specialty (NASDAQ:SKWD) has received various analyst ratings in the last quarter, with a total of 2 bullish, 2 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for the company, according to 6 analysts, is $29.17, which has increased by 5.69% over the past month.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 8:00 pm

HLGN

Heliogen has been granted U.S. Patent #11732928 for a 'Receiver For Capturing Solar Energy'. Following this news, the company's shares have seen a significant increase.

Portfolio Pulse from Happy Mohamed

August 22, 2023 | 7:58 pm

HIBB

Telsey Advisory Group analyst Cristina Fernandez reiterated an Outperform rating on Hibbett, Inc. (NASDAQ:HIBB) with a price target of $60. Despite choppy spending trends and a promotional environment for athletic footwear, the analyst believes Hibbett's Q2 expectations are achievable. The company is expected to have reduced inventory levels and is participating in the Yeezy drops in August, which could boost sales and online traffic. However, the analyst predicts an operating margin contraction in Q2 due to higher promotional activity and occupancy deleverage.

Portfolio Pulse from Nabaparna Bhattacharya

August 22, 2023 | 7:57 pm

ARAV

Aravive shares are trading lower after Cantor Fitzgerald downgraded the stock from Overweight to Neutral and lowered its price target from $18 to $0.25.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 7:53 pm